{"entity":{"type":"insider","cik":"0001612343","url":"/insider/0001612343","json_url":"/insider/0001612343.json","name":"EW Healthcare Partners, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":11,"first":"2017-11-21","last":"2023-09-06","span_basis":"filed_date"},"name_variants":[{"name":"EW Healthcare Partners, L.P.","source":"filing","n_filings":10,"first_seen":"2018-04-02","last_seen":"2023-09-06"},{"name":"Essex Woodlands Fund IX, L.P.","source":"filing","n_filings":1,"first_seen":"2017-11-21","last_seen":"2017-11-21"}],"transactions":[{"id":9205379,"accession":"0000899243-23-018661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018661","line_url":"/filing/0000899243-23-018661#line-1","is_derivative":false,"issuer_cik":"0001612343","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001612343","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.8991,"price_display":"9.90","price_state":"stated","total_value":197982.0,"total_display":"197,982.00","total_whole":"197,982","shares_owned_after":3490921.0,"shares_owned_after_display":"3,490,921","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":8507200,"accession":"0000899243-23-018658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018658","line_url":"/filing/0000899243-23-018658#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC; EW Healthcare Partners, L.P.","owner_display_name":"EW Healthcare Partners-A, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.8991,"price_display":"9.90","price_state":"stated","total_value":197982.0,"total_display":"197,982.00","total_whole":"197,982","shares_owned_after":3490921.0,"shares_owned_after_display":"3,490,921","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":8244838,"accession":"0000899243-23-018636","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-018636","line_url":"/filing/0000899243-23-018636","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Essex Woodlands Fund IX-GP, L.P.; EW Healthcare Partners-A, L.P.; EW Healthcare Partners, L.P.; Essex Woodlands IX, LLC","owner_display_name":"Essex Woodlands Fund IX-GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78495.0,"shares_display":"78,495","price_per_share":10.24346948977642,"price_display":"10.24","price_state":"stated","total_value":804061.1376,"total_display":"804,061.14","total_whole":"804,061","shares_owned_after":3517938.0,"shares_owned_after_display":"3,517,938","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-01","scope":"insider","n_lines":2},{"id":8244832,"accession":"0000899243-23-018636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-018636","line_url":"/filing/0000899243-23-018636","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Essex Woodlands Fund IX-GP, L.P.; EW Healthcare Partners-A, L.P.; EW Healthcare Partners, L.P.; Essex Woodlands IX, LLC","owner_display_name":"Essex Woodlands Fund IX-GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60976.0,"shares_display":"60,976","price_per_share":10.924744064877984,"price_display":"10.92","price_state":"stated","total_value":666147.1941,"total_display":"666,147.19","total_whole":"666,147","shares_owned_after":3589743.0,"shares_owned_after_display":"3,589,743","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-30","filed_date":"2023-09-01","scope":"insider","n_lines":2},{"id":8644921,"accession":"0000899243-23-018610","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-018610","line_url":"/filing/0000899243-23-018610","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Essex Woodlands IX, LLC; EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.","owner_display_name":"Essex Woodlands IX, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87854.0,"shares_display":"87,854","price_per_share":10.74765808728117,"price_display":"10.75","price_state":"stated","total_value":944224.7536,"total_display":"944,224.75","total_whole":"944,225","shares_owned_after":3650957.0,"shares_owned_after_display":"3,650,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-30","scope":"insider","n_lines":2},{"id":8644915,"accession":"0000899243-23-018610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018610","line_url":"/filing/0000899243-23-018610#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Essex Woodlands IX, LLC; EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.","owner_display_name":"Essex Woodlands IX, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60858.0,"shares_display":"60,858","price_per_share":11.7101,"price_display":"11.71","price_state":"stated","total_value":712653.2658,"total_display":"712,653.27","total_whole":"712,653","shares_owned_after":3738246.0,"shares_owned_after_display":"3,738,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":9205377,"accession":"0000899243-23-018606","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-018606","line_url":"/filing/0000899243-23-018606","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84656.0,"shares_display":"84,656","price_per_share":11.001313551313551,"price_display":"11.00","price_state":"stated","total_value":931327.2,"total_display":"931,327.20","total_whole":"931,327","shares_owned_after":3810835.0,"shares_owned_after_display":"3,810,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-08-30","scope":"insider","n_lines":2},{"id":8465264,"accession":"0000950170-23-044843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-044843","line_url":"/filing/0000950170-23-044843","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84656.0,"shares_display":"84,656","price_per_share":11.003109317709317,"price_display":"11.00","price_state":"stated","total_value":931479.2224,"total_display":"931,479.22","total_whole":"931,479","shares_owned_after":3799104.0,"shares_owned_after_display":"3,799,104","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-08-28","scope":"insider","n_lines":2},{"id":9205378,"accession":"0000899243-23-018606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018606","line_url":"/filing/0000899243-23-018606","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139280.0,"shares_display":"139,280","price_per_share":11.172851809304998,"price_display":"11.17","price_state":"stated","total_value":1556154.8,"total_display":"1,556,154.80","total_whole":"1,556,155","shares_owned_after":3935940.0,"shares_owned_after_display":"3,935,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-30","scope":"insider","n_lines":2},{"id":8465255,"accession":"0000950170-23-044843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-044843","line_url":"/filing/0000950170-23-044843#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139280.0,"shares_display":"139,280","price_per_share":14.6187,"price_display":"14.62","price_state":"stated","total_value":2036092.536,"total_display":"2,036,092.54","total_whole":"2,036,093","shares_owned_after":3883760.0,"shares_owned_after_display":"3,883,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-28","scope":"insider"},{"id":7939406,"accession":"0000899243-23-018380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-018380","line_url":"/filing/0000899243-23-018380#line-2","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; Essex Woodlands IX, LLC; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121103.0,"shares_display":"121,103","price_per_share":13.0543,"price_display":"13.05","price_state":"stated","total_value":1580914.8929,"total_display":"1,580,914.89","total_whole":"1,580,915","shares_owned_after":4023040.0,"shares_owned_after_display":"4,023,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-24","scope":"insider"},{"id":7939404,"accession":"0000899243-23-018380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018380","line_url":"/filing/0000899243-23-018380#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; Essex Woodlands IX, LLC; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46778.0,"shares_display":"46,778","price_per_share":14.6187,"price_display":"14.62","price_state":"stated","total_value":683833.5486,"total_display":"683,833.55","total_whole":"683,834","shares_owned_after":4144143.0,"shares_owned_after_display":"4,144,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-24","scope":"insider"},{"id":5470023,"accession":"0001140361-21-042316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-21-042316","line_url":"/filing/0001140361-21-042316","is_derivative":false,"issuer_cik":"0001409269","issuer_name":"Venus Concept Inc.","issuer_ticker":"VERO","issuer_name_source":null,"issuer_url":"/issuer/0001409269","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3920000.0,"shares_display":"3,920,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":4900000.0,"total_display":"4,900,000.00","total_whole":"4,900,000","shares_owned_after":15705966.0,"shares_owned_after_display":"15,705,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider","n_lines":2},{"id":6316039,"accession":"0000899243-18-019313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-019313","line_url":"/filing/0000899243-18-019313","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Essex Woodlands Fund IX-GP, L.P.; Essex Woodlands IX, LLC; EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.","owner_display_name":"Essex Woodlands Fund IX-GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16864066.0,"shares_display":"16,864,066","price_per_share":1.265,"price_display":"1.26","price_state":"stated","total_value":21333043.49,"total_display":"21,333,043.49","total_whole":"21,333,043","shares_owned_after":25470390.0,"shares_owned_after_display":"25,470,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-07-03","scope":"insider","n_lines":2},{"id":6646734,"accession":"0000899243-18-009028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-009028","line_url":"/filing/0000899243-18-009028","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"PSDV","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"EW Healthcare Partners, L.P.; EW Healthcare Partners-A, L.P.; Essex Woodlands IX, LLC; Essex Woodlands Fund IX-GP, L.P.","owner_display_name":"EW Healthcare Partners, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8606324.0,"shares_display":"8,606,324","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":9466956.4,"total_display":"9,466,956.40","total_whole":"9,466,956","shares_owned_after":8606324.0,"shares_owned_after_display":"8,606,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-28","filed_date":"2018-04-02","scope":"insider","n_lines":2},{"id":5202347,"accession":"0000899243-17-027156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-027156","line_url":"/filing/0000899243-17-027156#line-1","is_derivative":false,"issuer_cik":"0000805928","issuer_name":"AxoGen, Inc.","issuer_ticker":"AXGN","issuer_name_source":null,"issuer_url":"/issuer/0000805928","owner_cik":"0001612343","owner_name":"Essex Woodlands Fund IX, L.P.","owner_display_name":"Essex Woodlands Fund IX, L.P.","owner_url":"/insider/0001612343","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1150000.0,"shares_display":"1,150,000","price_per_share":19.74,"price_display":"19.74","price_state":"stated","total_value":22701000.0,"total_display":"22,701,000.00","total_whole":"22,701,000","shares_owned_after":3711111.0,"shares_owned_after_display":"3,711,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint Pharmaceuticals, Inc.","url":"/issuer/0001314102","role":"Ten percent owner, Other","n_filings":9,"first_seen":"2018-04-02","last_seen":"2023-09-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001409269","name":"Venus Concept Inc.","url":"/issuer/0001409269","role":"Ten percent owner","n_filings":1,"first_seen":"2021-12-17","last_seen":"2021-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000805928","name":"AxoGen, Inc.","url":"/issuer/0000805928","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-21","last_seen":"2017-11-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612343","retrieved_at":"2026-08-22T22:02:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}